'He wants people that can disrupt alongside him' One by one, they had all trickled into the walnut-paneled Mansfield Room. Donald Trump had just made another improbable return: his first visit to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Techne awards up to 57 AHRC/UKRI studentships each year across the range of arts and humanities disciplines: 45 in its open competition and 12 through the Collaborative Doctoral Awards scheme.

This PhD is funded by the AHRC Techne Collaborative Doctoral Award (CDA) and the University of Surrey. The successful candidate will be supervised by world-leading scholars at the Centre for ...

When it comes to clip vs magazine, there seems to be some confusion among many shooters, or at least a tendency to say one when we mean to other. Both “clip” and “magazine” describe a ...

Kemi Badenoch has rejected a suggestion the Tories could merge with Reform UK to beat Labour in the next election. The Conservative leader also criticised the actions of Tory-led governments she ...

The Today show crew is preparing to say their final goodbye as Hoda Kotb hosts her last show on Friday, January 10. After seven years in the co-anchor seat next to Savannah Guthrie, Kotb is ...

MINNEAPOLIS, Jan. 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and ...

How the dream of a lifetime became reality for a sculptor from Egypt. A new wooden sculpture on display at the Metropolitan Museum of Art has a fascinating back story.Credit...Graham Dickie/The ...

The February 2025 issue of CAR magazine is on sale now – and you can check out some of the content now, for free, by browsing our app. Click here to download from the App Store for iPhone ...

MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies ...